LifeSign Status™ COVID-19/Flu A&B

Status™ COVID-19/Flu A&B - 25 Test Kit

A rapid immunoassay for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, influenza type A and type B antigens from anterior nasal and nasopharyngeal swab specimens.

• FDA Emergency Use Authorization (EUA)
• 25 Tests per Kit
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort

Clinical Performance:

• COVID-19
  - Anterior Nasal Swab Specimen - Sensitivity 93.8 %, Specificity 100%
  - Nasopharyngeal Swab Specimen - Sensitivity 93.1 %, Specificity 100%

• Flu A - Sensitivity 91.4%, Specificity 95.7%
• Flu B - Sensitivity 87.6%, Specificity 95.9%